Abstract
This review focuses on the recent developments and future trends dealing with its modifications, encompassing the different grades of polymethacrylates polymers based formulations. The last three decades of pioneering works explain it as a new functional material of high potential value in novel drug delivery. Polymethacrylates are synthetic cationic and anionic copolymers of dimethylaminoethyl methacrylates, methacrylic acid, and methacrylic acid esters in varying ratios, generating a new and modified patterned polymer due to their electrical characters and pH- dependent solubility. Based on current research and existing products, some new and futuristic approaches in this fascinating area have been thoroughly explored and discussed. These polymers are used as release retardant in different formulations like oral capsules and tablets, film-coating agents for protective purposes and provide sustained release formulations. This review also screens the current applications of these polymers in the development of microparticles, patches, nanoparticles, colon targeted formulations, ophthalmic, vaccine delivery, taste masking agent and its pivotal application in gene delivery systems. This work summarizes the achievements of past which can be extrapolated to characterize the possible array of polymeric interactions, exploiting their desirable properties for future studies.
Keywords: Applications, polymethacrylates, review
Current Drug Therapy
Title:Applicability and Approaches of (Meth) Acrylate Copolymers (Eudragits) in Novel Drug Delivery Systems
Volume: 7 Issue: 4
Author(s): Kumar Animesh, Moin Afrasim, Rami R. Bommareddy, Ahmed Ayaz, Ravi Shruthi and Hoskote G. Shivakumar
Affiliation:
Keywords: Applications, polymethacrylates, review
Abstract: This review focuses on the recent developments and future trends dealing with its modifications, encompassing the different grades of polymethacrylates polymers based formulations. The last three decades of pioneering works explain it as a new functional material of high potential value in novel drug delivery. Polymethacrylates are synthetic cationic and anionic copolymers of dimethylaminoethyl methacrylates, methacrylic acid, and methacrylic acid esters in varying ratios, generating a new and modified patterned polymer due to their electrical characters and pH- dependent solubility. Based on current research and existing products, some new and futuristic approaches in this fascinating area have been thoroughly explored and discussed. These polymers are used as release retardant in different formulations like oral capsules and tablets, film-coating agents for protective purposes and provide sustained release formulations. This review also screens the current applications of these polymers in the development of microparticles, patches, nanoparticles, colon targeted formulations, ophthalmic, vaccine delivery, taste masking agent and its pivotal application in gene delivery systems. This work summarizes the achievements of past which can be extrapolated to characterize the possible array of polymeric interactions, exploiting their desirable properties for future studies.
Export Options
About this article
Cite this article as:
Animesh Kumar, Afrasim Moin, R. Bommareddy Rami, Ayaz Ahmed, Shruthi Ravi and G. Shivakumar Hoskote, Applicability and Approaches of (Meth) Acrylate Copolymers (Eudragits) in Novel Drug Delivery Systems, Current Drug Therapy 2012; 7 (4) . https://dx.doi.org/10.2174/157488512804999082
DOI https://dx.doi.org/10.2174/157488512804999082 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Improving Cancer Chemotherapy with Modulators of ABC Drug Transporters
Current Drug Targets The Impact of Comorbid Diabetes Type 2 on Quality of Life in Cancer Patients Undergoing Chemotherapy
Endocrine, Metabolic & Immune Disorders - Drug Targets G-Protein Coupled Receptor 124 (GPR124) in Endothelial Cells Regulates Vascular Endothelial Growth Factor (VEGF)-Induced Tumor Angiogenesis
Current Molecular Medicine Molecular Targeted Approaches to Cancer Therapy and Prevention Using Chalcones
Current Cancer Drug Targets Overview of Tumor-Associated Antigens (TAAs) as Potential Therapeutic Targets for Prostate Cancer Therapy
Current Cancer Therapy Reviews Modulation of Photosensitization Processes for an Improved Targeted Photodynamic Therapy
Current Medicinal Chemistry Biomarkers for Risk Assessment and Prevention of Breast Cancer
Current Cancer Drug Targets Treatment of Colorectal Liver Metastases: A Review
Reviews on Recent Clinical Trials NK Cell Receptor and MHC Gene Polymorphisms, Potential Relevance in Malignancies
Current Cancer Therapy Reviews QSPR and Flow Cytometry Analysis (QSPR-FCA): Review and New Findings on Parallel Study of Multiple Interactions of Chemical Compounds with Immune Cellular and Molecular Targets
Current Drug Metabolism The Journey From Metabolic Profiling to Biomarkers: The Potential of NMR Spectroscopy Based Metabolomics in Neurodegenerative Disease Research
Current Metabolomics Diastereoselective Addition of Organometallic Reagents to Diimines Derived from (R,R)-1,2-Diaminocyclohexane and Aromatic Aldehydes
Letters in Organic Chemistry Endoglin Silencing has Significant Antitumor Effect on Murine Mammary Adenocarcinoma Mediated by Vascular Targeted Effect
Current Gene Therapy Natural History of Ulcerative Colitis: Current Knowledge
Current Drug Targets Ribosomal Proteins and Colorectal Cancer
Current Genomics Therapeutic Potential of Plant Extracts and Phytochemicals Against Brain Ischemia-Reperfusion Injury: A Review
The Natural Products Journal Current Treatment Strategies for Multiple Sclerosis - Efficacy Versus Neurological Adverse Effects
Current Pharmaceutical Design Genomic Organization and Control of the Grb7 Gene Family
Current Genomics Current Molecularly Targeting Therapies in NSCLC and Melanoma
Anti-Cancer Agents in Medicinal Chemistry Antiangiogenic Drugs in the Treatment of Advanced Epithelial Ovarian Cancer
Anti-Cancer Agents in Medicinal Chemistry